Literature DB >> 22346245

Estrogen, male dominance and esophageal adenocarcinoma: is there a link?

Huiqi Yang, Olga A Sukocheva, Damian J Hussey, David I Watson.   

Abstract

Esophageal adenocarcinoma is a cancer with poor prognosis, and its incidence has risen sharply over recent decades. Obesity is a major risk factor for developing this cancer and there is a clear male gender bias in the incidence that cannot be fully explained by known risk factors. It is possible that a difference in the expression of estrogen, or its signaling axes, may contribute to this gender bias. We undertook a comprehensive literature search and analyzed the available data regarding estrogen and estrogen receptor expression, and the possible sex-specific links with esophageal adenocarcinoma development. Potentially relevant associations between visceral vs subcutaneous fat deposition and estrogen expression, and the effect of crosstalk between estrogen and leptin signaling were identified. We also found limited studies suggesting a role for estrogen receptor β expression in esophageal adenocarcinoma development. The current literature supports speculation on an etiological role for estrogen in the male gender bias in esophageal adenocarcinoma, but further studies are required.

Entities:  

Keywords:  Esophageal adenocarcinoma; Estrogen; Estrogen receptors; Male dominance

Mesh:

Substances:

Year:  2012        PMID: 22346245      PMCID: PMC3270506          DOI: 10.3748/wjg.v18.i5.393

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  88 in total

1.  Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity.

Authors:  G Speer; K Cseh; G Winkler; P Vargha; E Braun; I Takács; P Lakatos
Journal:  Eur J Endocrinol       Date:  2001-04       Impact factor: 6.664

Review 2.  Estrogens in males: what have we learned in the last 10 years?

Authors:  Vincenzo Rochira; Antonio R M Granata; Bruno Madeo; Lucia Zirilli; Giuseppina Rossi; Cesare Carani
Journal:  Asian J Androl       Date:  2005-03       Impact factor: 3.285

3.  Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.

Authors:  C A Bandera; H Takahashi; K Behbakht; P C Liu; V A LiVolsi; I Benjamin; M A Morgan; S A King; S C Rubin; J Boyd
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma.

Authors:  Liang Liu; Minni Chirala; Mamoun Younes
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

Review 5.  The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men.

Authors:  John J Cho; Patrick Cadet; Elliott Salamon; Kirk Mantione; George B Stefano
Journal:  Med Sci Monit       Date:  2003-03

6.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

Authors:  L E Rutqvist; H Johansson; T Signomklao; U Johansson; T Fornander; N Wilking
Journal:  J Natl Cancer Inst       Date:  1995-05-03       Impact factor: 13.506

7.  Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

Authors:  P Pujol; J M Rey; P Nirde; P Roger; M Gastaldi; F Laffargue; H Rochefort; T Maudelonde
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

8.  Genomic instability occurs in colorectal carcinomas but not in adenomas.

Authors:  J Young; B Leggett; C Gustafson; M Ward; J Searle; L Thomas; R Buttenshaw; G Chenevix-Trench
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.

Authors:  L Huiart; S Dell'Aniello; S Suissa
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

View more
  21 in total

1.  Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis.

Authors:  Michael B Cook; Shannon N Wood; Brooks D Cash; Patrick Young; Ruben D Acosta; Roni T Falk; Ruth M Pfeiffer; Nan Hu; Hua Su; Lemin Wang; Chaoyu Wang; Barbara Gherman; Carol Giffen; Cathy Dykes; Veronique Turcotte; Patrick Caron; Chantal Guillemette; Sanford M Dawsey; Christian C Abnet; Paula L Hyland; Philip R Taylor
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-24       Impact factor: 11.382

2.  17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.

Authors:  Justin C Wheeler; Simone Vanoni; Chang Zeng; Lisa Waggoner; Yanfen Yang; David Wu; Jazib Uddin; Rebekah Karns; Leah Kottyan; Vincent Mukkada; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 10.793

3.  Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study.

Authors:  M B Cook; S Wood; P L Hyland; P Caron; J Drahos; R T Falk; R M Pfeiffer; S M Dawsey; C C Abnet; P R Taylor; C Guillemette; L J Murray; L A Anderson
Journal:  Andrology       Date:  2017-02-27       Impact factor: 3.842

Review 4.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  The inhibitory effects of Endostar combined with chemotherapy on human esophageal squamous cell carcinoma xenograft in mice.

Authors:  Liang Chang; Fengjie Guo; Yalei Lv; Yudong Wang; Bingjie Huo; Long Wang; Wei Liu
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

6.  Estrogen Receptors in Regulating Cell Proliferation of Esophageal Squamous Cell Carcinoma: Involvement of Intracellular Ca2+ Signaling.

Authors:  Zhe Zhang; Qinsi He; Si Fu; Zhi Zheng
Journal:  Pathol Oncol Res       Date:  2016-09-05       Impact factor: 3.201

7.  Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Authors:  Jessica L Petrick; Paula L Hyland; Patrick Caron; Roni T Falk; Ruth M Pfeiffer; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Susan M Gapstur; Gary Bradwin; Chantal Guillemette; Peter T Campbell; Michael B Cook
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

8.  Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.

Authors:  Wenwu Dong; Jing Li; Hao Zhang; Yanhong Huang; Liang He; Zhihong Wang; Zhongyan Shan; Weiping Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 9.  The roles of estrogen and estrogen receptors in gastrointestinal disease.

Authors:  Changmei Chen; Xiang Gong; Xiaoxu Yang; Xianhui Shang; Qian Du; Qiushi Liao; Rui Xie; Yuanshou Chen; Jingyu Xu
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

10.  Unique Considerations for Females Undergoing Esophagectomy.

Authors:  Tamar B Nobel; Jennifer Livschitz; Mahmoud Eljalby; Yelena Y Janjigian; Manjit S Bains; Prasad S Adusumilli; David R Jones; Daniela Molena
Journal:  Ann Surg       Date:  2020-07       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.